HEFT Pathology Guideline. GP Investigation and Referral Pathways for leucocyte, platelet disturbances and polycythaemia

Similar documents
GP Referral Guidelines. for. South Wales Cancer Network. Document Control Sheet. Specialty/Project Haematological Site Specific Group

King s Health Partners Haematology Institute and Network GP Referral Guide, Adult Haematology

King s Health Partners Haematology Institute and Network GP Referral Guide, Adult Haematology

Haematology for GP's

Haematology dilemma s to refer or not to refer?

Western Health Specialist Clinics Access & Referral Guidelines

Leukocytosis - Some Learning Points

Clinical & Laboratory Assessment

Haematological Cancer Suspected (Adults & Children)

By Angela Gascoigne Haematology CNS Chesterfield Royal Hospital

GP CME. James Liang Consultant Haematologist. Created by: Date:

Department of Clinical Haematology

Borderline cytopenias. Dr Taku Sugai Consultant Haematologist

Diseases Of The Blood

Complete Blood Count PSI AP Biology

UH Bristol Haematology Referral Guidelines for Primary Care

Morphology Case Study. Presented by Niamh O Donnell, BSc, MSc. Medical Scientist Haematology Laboratory Cork University Hospital

Interpreting Blood Tests Part 1. Dr Andrew Smith

DIAGNOSIS IN PRIMARY CARE AND REFERRAL PATHWAY FOR PATIENTS WITH A RAISED HAEMATOCRIT

Complete Blood Count in Primary Care

Common Haematological Problems in Primary Care

Abnormal blood counts in children Dr Tina Biss Consultant Paediatric Haematologist Newcastle upon Tyne Hospitals NHS Foundation Trust

MYELOPROLIFARATIVE NEOPLASMS. Dr. Hasan Fahmawi, MRCP(UK), FRCP(Edin).

Platelet and WBC disorders

Michael Joffe ST6 Haematology SpR

Contents SECTION 1: PHYSIOLOGY OF BLOOD

Early diagnosis saves lives #SpotLeukaemia

Chronic Myeloproliferative Disorders

Taking The Fear Out of Abnormal CBC s Problems of Production, Destruction or loss

Common Consultations in Outpatient Hematology in 30 mins. Lala Cornelius, MD

Idiopathic Thrombocytopenic Purpura

BIOS222 Pathology and Clinical Science 2

The Complete Blood Count

Dr Marina Karakantza Consultant Haematologist, NHSBT

Rory McCulloch. Specialty Trainee Haematology Royal Devon & Exeter Hospital

Leukocytosis. dr. Erdélyi, Dániel 2 nd Department of Paediatrics Semmelweis University

How to monitor MPN patients

Cytopaenias in HIV. Dr Maresce Bizaare Specialist Physician Clinical Haematology Fellow IALCH

HYDROXYCARBAMIDE for Haematological conditions (Adults)

5/5/2010. Goldilocks picture from

Candidates must answer ALL questions

Haematology update. Page 2 Haematology in the elderly. Page 4 CRP, ESR and the inflammatory response. Dr Claudine Ho.

Guidelines for diagnosis and management of adult myeloproliferative neoplasms (PV, ET, PMF and HES)

Prescribing Framework for Mycophenolate Mofetil for Immunosuppression in ADULTs

Leukemias. Prof. Mutti Ullah Khan Head of Department Medical Unit-II Holy Family Hospital Rawalpindi Medical College

FBC interpretation. Dr. Gergely Varga

Polycythemia Vera and other Myeloproliferative Neoplasms. A.Mousavi

Cancer in Children. Dr Anant Sachdev Cancer Lead Berkshire East, GPSI Palliative Medicine

FBC CASES Vernon Louw Clinical Haematology 2010

R-FC for Chronic Lymphocytic Leukaemia LKWOS-005/01

Disorders of Blood Cells & Blood Coagulation

High Intensity Chemotherapy Guidelines for Haematology Patients at ASPH

Anaemias and other Pesky Haematology Questions

PATHOLOGY & PATHOPHYSIOLOGY

Chest diseases Hospital Hematology Patient care plans

٢٨/٠١/١٤٣٧. Prof. M. Rushdi.

What is a hematological malignancy? Hematology and Hematologic Malignancies. Etiology of hematological malignancies. Leukemias

Polycthemia Vera (Rubra)

POSTGRADUATE INSTITUTE OF MEDICINE UNIVERSITY OF COLOMBO POSTGRADUATE DIPLOMA IN CLINICAL HAEMATOLOGY EXAMINATION - JUNE 2014 PAPER I - ESSAY

Laboratory Empowerment. Debbie Asher Adrian Ebbs Transfusion Laboratory Managers, Eastern Pathology Alliance

Clinical implications for decreased lymphocytes (lymphopenia) o Corticosteroid therapy, adrenocortical hyperfunction, stress, shock

Blood Cancers in the Community

Things to never miss in the office. Brett Houston MD FRCPC (PYG-5, hematology) Leonard Minuk MD FRCPC

Chapter 3 Diseases of the Blood and Bloodforming Organs and Certain Disorders Involving the Immune Mechanism D50-D89

Clinical Guidelines for Leukaemia and other Myeloid Disorders Myeloproliferative Neoplasms

Full Blood Count analysis Is a 3 part-diff good enough? Dr Marion Münster, Sysmex South Africa

Pathology of Hematopoietic and Lymphoid tissue

Part 1 examination. Haematology: First paper. Tuesday 20 March Candidates must answer all questions. Each question is worth a total of 25 marks.

Myeloproliferative Disorders - D Savage - 9 Jan 2002

Complete Blood Count (CBC) Assist.Prof. Filiz BAKAR ATEŞ

Cancer: NICE (symptom based)- what s new November 2016

Year 2003 Paper two: Questions supplied by Tricia

SCOTTISH CANCER REFERRAL GUIDELINES REVIEW 2018

BONE MARROW EXAMINATION FINDINGS AT AGA KHAN UNIVERSITY HOSPITAL, NAIROBI

Myeloproliferative Disorders in the Elderly: Clinical Presentation and Role of Bone Marrow Examination

Guidelines for the Management of Chronic Lymphocytic Leukaemia (CLL)

TESTS: Baseline tests: - FBC, U&Es, LFTs, creatinine. - Physical exam including splenic measurement by palpation - Weight - ECG, blood pressure.

SB 6331 (scanned slide available) Keith Duncan; Mills-Peninsula Hospital 52-year-old male with painful right parotid mass.

Disclosures. Myeloproliferative Neoplasms: A Case-Based Approach. Objectives. Myeloproliferative Neoplasms. Myeloproliferative Neoplasms

June Ruxolitinib for the second-line treatment of myelofibrosis (IPSS intermediate LONDON CANCER NEWS DRUGS GROUP RAPID REVIEW

Maresce Bizaare AWACC 2013

Case History: A 45 Year Old Female Presenting with Fatigue, High Platelets and Splenomegaly. Clinical Approach, Investigations and Management

Understanding Your Blood Work Results

HAEMATOLOGICAL MALIGNANCY

The drug cost of lenalidomide for people who remain on treatment for more than 26 cycles will be met by the company.

in people with intermediate 2 or high-risk disease, AND if the company provides ruxolitinib with the discount agreed in the patient access scheme.

NCCP Chemotherapy Regimen

Abnormal Blood Counts: To Refer or not to Refer? Dr Arne de Kreuk Haematology Consultant Croydon Health Services NHS Trust

GP refresher course Anaemia. Peter MacCallum Consultant Haematologist Barts Health NHS Trust London January 2018

Clozapine and Polycythemia Rubra Vera: A Rare Side Effect or a Separate Medical Condition? A Case Report

r). SUPPLEMENTARY/SECOND OPPORTUNITY EXAMINATION PAPER nnmlbih UNIVERSITY Sophia Blaauw INSTRUCTIONS FACULTY OF HEALTH AND APPLIED SCIENCES

Pathology of Hematopoietic and Lymphoid tissue

MYELOPROLIFERATIVE DISEASE. Dr Mere Kende MBBS (UPNG), MMED (Path),MAACB, MACTM, MACRRM (Aus) Lecturer-SMHS UPNG

Drug regimen Supplied as 2mg tablets. Doses should be rounded to nearest 2mg. Initial daily maximum of 4 mg, which may be given as a single dose.

UNUSUAL PRESENTATION OF AN USUAL CAUSE OF THROMBOCYTOPENIA SOUTHERN RAILWAY HQ HOSPITAL, PERAMBUR DR. KUMARAN DNB PG

Haematology Team431 3/4. White Blood Cells. Abdulrahman Alkadhaib & Alaa Alanazi. Mohammed Page 1 Al-Dhaheri

حسام أبو عوض- -Jaleel Sweis سليم خريشة-

Pediatric Oncology. Vlad Radulescu, MD

NHS Basildon & Brentwood Clinical Commissioning Group. Unplanned & Planned Care Pathways. Adam Cronin BBCCG - Version 2 (April 2013),

NICE guideline on Suspected cancer: recognition and referral (2015) Education package for GPs and Nurse Practitioners Case scenarios

Transcription:

HEFT Pathology Guideline GP Investigation and Referral Pathways for leucocyte, platelet disturbances and polycythaemia Produced by: Dr Charalampos Kartsios (Consultant Haematologist) and Muhammad Javed Khan (Senior Biomedical Scientist) Active Date: 08/01/2017 Review Date: 08/01/2019

1. Leucocytosis 2. Lymphocytosis in Adults 3. Neutropenia 4. Polycythaemia 5. Thrombocytosis 6. Thrombocytopenia HEFT Pathology Guideline: Leucocyte, platelet disturbances and polycythaemia Active date: 18/01/2017 Review date: 18/01/2019

Sheet 1. Leucocytosis Leukocytosis is defined as a total WBC count greater than 11 x 10 9 /l in adults. No clinical action is required for a WBC greater than 8.4 but less than 11.0 Leucocytosis WBC >11 but <20 Blood film/wbc differential Assess for reactive causes: smoking infection inflammation neoplasia Lymph node/spleen exam Suspicion of blood malignancy or Inconclusive investigations Persistent, unexplained: WBC > 20 but < 50 Neutrophils >15 Eosinophilia, Monocytosis, Basophilia WBC >50 but < 100 Leucoerythroblastic blood film picture Film suggestive of Chronic Myeloid Leukaemia URGENT REFERRAL New suspected Acute Leukaemia Film suggestive of Chronic Myeloid Leukaemia with either WBC >100 or CNS symptoms (headache, visual loss, vomiting) Seek Haematology CONTACT ON CALL HAEMATOLOGIST

Sheet 2. Lymphocytosis Lymphocytosis is defined as a total LYMPH count greater than 4 x 10 9 /l in adults. Lymphocytosis in Adults LYMPH> 20 or rapidly raising and: Anaemia Neutropenia Thrombocytopenia Progressive Lymphadenopathy B symptoms: unexplained weight loss night sweats evening temperature Presence of suspicious cells/ blasts on blood film LYMPH > 5 but < 20 Criteria not met for urgent referral Lymph node/spleen exam Blood film/wbc differential Glandular fever screen Exclude reactive causes: smoking other viral infection Reactive cause identified? URGENT REFERRAL YES Repeat FBC in 6 weeks to confirm transient nature NO Seek Haematology

Sheet 3. Neutropenia Neutropenia is defined as a total NEU count less than 2 x 10 9 /l in adults. Complications are associated to the depth of neutropenia. Only patients with a NEU count < 1 x 10 9 /l need review by Haematology; a NEU count < 0.5 is associated with a major infection risk. Neutropenia NEU < 1 associated with: Anaemia Thrombocytopenia Lymphadenopathy Organomegaly Active sepsis B symptoms: unexplained weight loss night sweats evening temperature Presence of suspicious cells/ blasts on blood film NEU < 1 and criteria not met for urgent referral NEU > 1 but < 2 Blood film/wbc differential Exclude viral infection Autoimmune profile Check medication Consider ethnic neutropenia; Middle east, African, Caribbean origin Repeat FBC in 3-4 weeks STABLE NEU FALLING NEU URGENT REFERRAL/ DISCUSSION WITH ON CALL HAEATOLOGIST Monitor FBC every 3 months Seek Haematology

Sheet 4. Polycythaemia Elevated Hb/Hct has a wide differential diagnosis including polycythaemia vera, relative polycythaemia and secondary causes like smoking and COPD. Raised Haematocrit Hct > 0.60 in males, > 0.56 in females and absence of congenital cyanotic heart disease Persistently raised Hct > 0.51 in males, > 0.48 in females and: neurological symptoms, visual loss, abnormal bleeding, recent thrombotic event, raised WBC count and/or raised PLT count Criteria not met for urgent referral Repeat FBC to confirm Spleen exam Check for pruritus Blood film Check O 2 saturation and exclude: COPD, sleep apnoea Modify lifestyle factors: smoking Check medication and stop diuretics Secondary cause identified? URGENT REFERRAL YES Hct < 0.54 Monitor FBC every 3 months Hct 0.54 Refer to Haematology for venesection NO Seek Haematology

Sheet 5. Thrombocytosis Thrombocytosis is defined as a PLT count more than 450 x 10 9 /l. A common cause of thrombocytosis is iron deficiency. PLT > 450 PLT > 1000 PLT > 450 and: neurological symptoms abnormal bleeding recent thrombotic event: DVT/PE, TIA/CVA, MI/unstable angina, vascular disease Criteria not met for urgent referral Repeat FBC to confirm Look for reactive causes Infection Inflammation Neoplasia Check ferritin / iron kinetics Spleen exam Blood film Secondary cause identified? URGENT REFERRAL YES Act as per diagnosis NO Seek Haematology

Sheet 6. Thrombocytopenia Thrombocytopenia is defined as a PLT count below 150 x 10 9 /l. Most patients with PLT > 50 are asymptomatic. The risk of bleeding is increasing with a PLT count below 20. PLT < 150 PLT <50 PLT 50-100 and: severe anaemia/neutropenia splenomegaly lymphadenopathy pregnancy upcoming surgery history of thrombosis Criteria not met for urgent referral Repeat FBC to confirm Blood film Autoimmune profile Alcohol history/liver biochemistry Exclude viral infection HIV/Hepatitis screen Check medication Secondary cause identified? URGENT REFERRAL/ DISCUSSION WITH ON CALL HAEMATOLOGIST YES Act as per diagnosis NO Seek Haematology PATIENTS WITH PLT <20 AND ACTIVE BLEEDING SHOULD BE DIRECTED TO A&E ASAP